Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Leo

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
European Review for Medical and Pharmacological Sciences|December 18, 2020
Penile cancer: prognostic and predictive factors in clinical decision-makingC D'Aniello, C Cavaliere, B A Facchini, et al.
ESMO Open|April 30, 2021
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054]C De Angelis, D Bruzzese, A Bernardo, et al.
JAMA|May 28, 1997
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury StudyM B Bracken, M J Shepard, T R Holford, et al.
Journal of Neurosurgery|November 17, 1998
Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trialM B Bracken, M J Shepard, T R Holford, et al.
Journal of Science and Medicine in Sport|March 31, 2026
Normative values for hip strength and range of motion in Dutch professional female football players - PROFE hip studyS N L Sita Coenjaerts, T P A Tom Beddows, A W Adam Weir, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
European Review for Medical and Pharmacological Sciences|December 18, 2020
Penile cancer: prognostic and predictive factors in clinical decision-makingC D'Aniello, C Cavaliere, B A Facchini, et al.
ESMO Open|April 30, 2021
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054]C De Angelis, D Bruzzese, A Bernardo, et al.
JAMA|May 28, 1997
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury StudyM B Bracken, M J Shepard, T R Holford, et al.
Journal of Neurosurgery|November 17, 1998
Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trialM B Bracken, M J Shepard, T R Holford, et al.
Journal of Science and Medicine in Sport|March 31, 2026
Normative values for hip strength and range of motion in Dutch professional female football players - PROFE hip studyS N L Sita Coenjaerts, T P A Tom Beddows, A W Adam Weir, et al.
Pageof 11